For decades, farmers have faced a trade-off between size and flavor when growing tomatoes and eggplants. The hefty tomatoes ...

Johns Hopkins scientists say the innovation could bring 'new fruits, foods, and flavors' to an expanded global agricultural ...

Fintel reports that on March 5, 2025, HC Wainwright & Co. initiated coverage of Intellia Therapeutics (NasdaqGM:NTLA) with a ...

A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...

CRISPR is a technology that can be used to edit genes ... simply by giving it a piece of RNA to guide it in its search. When the CRISPR Cas9 protein is added to a cell along with a piece of ...

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...

The growing occurrence of genetic disorders like sickle cell anemia, cystic fibrosis, and muscular dystrophy is fueling the demand for gene therapy and genome editing solutions, as these approaches ...

The CRISPR/Cas9 gene editing technology uses a human engineered guide RNA to lead an enzyme called Cas9 to a specific region of DNA. Cas9 acts like a pair of “molecular scissors” and cuts the DNA.

H.C. Wainwright analyst Mitchell Kapoor initiated coverage of Intellia Therapeutics (NTLA) with a Buy rating and $30 price target Intellia is ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

Wugen, Inc., a clinical-stage U.S. biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological and solid tumor malignancies, today announced the ...